The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Prinovox 400 mg + 100 mg spot-on solution for extra-large dogs

400 + 100 mg/pipette Spot-on solution

Bayer LimitedVPA10021/075/004

Main Information

Trade NamePrinovox 400 mg + 100 mg spot-on solution for extra-large dogs
Active SubstancesImidacloprid
Moxidectin
Strength400 + 100 mg/pipette
Dosage FormSpot-on solution
Licence HolderBayer Limited
Licence NumberVPA10021/075/004

Group Information

ATC CodeQP54AB52 moxidectin, combinations
Therapeutic ClassEctoparasiticide
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued05/05/2017
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back